Literature DB >> 12511881

New insights into an enigmatic tumour suppressor.

Peter J Ratcliffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511881     DOI: 10.1038/ncb0103-7

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


× No keyword cloud information.
  5 in total

Review 1.  Hypoxic preconditioning protects against ischemic brain injury.

Authors:  Frank R Sharp; Ruiqiong Ran; Aigang Lu; Yang Tang; Kenneth I Strauss; Todd Glass; Tim Ardizzone; Myriam Bernaudin
Journal:  NeuroRx       Date:  2004-01

Review 2.  Signaling pathways in renal cell carcinoma.

Authors:  Gowrishankar Banumathy; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

3.  The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.

Authors:  Benedetta Peruzzi; Gagani Athauda; Donald P Bottaro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

4.  The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth.

Authors:  Bernhard Schermer; Cristina Ghenoiu; Malte Bartram; Roman Ulrich Müller; Fruzsina Kotsis; Martin Höhne; Wolfgang Kühn; Manuela Rapka; Roland Nitschke; Hanswalter Zentgraf; Manfred Fliegauf; Heymut Omran; Gerd Walz; Thomas Benzing
Journal:  J Cell Biol       Date:  2006-11-13       Impact factor: 10.539

5.  Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors.

Authors:  Giovanni Minervini; Raffaele Lopreiato; Raissa Bortolotto; Antonella Falconieri; Geppo Sartori; Silvio C E Tosatto
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.